Huber+suhner AG (HUBN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 156.20 |
|---|---|
| 52-week range | 138.00 – 288.00 |
| Return, 1 month / 3 months | −14.5% / −19.1% |
| Return, 1 year / 3 years | +11.9% / +175.0% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 45.3% |
| Worst drawdown (1 year) | -45.9% |
| Average daily value traded | 13.07M CHF |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Huber+Suhner is a Swiss manufacturer of electrical and optical connectivity products, including connectors, cable assemblies, cable systems and lightning protection components. It supplies these to customers in communication networks, transport such as rail and vehicles, and industrial applications, along with radio frequency and fibre optic solutions. The company is based in Herisau, Switzerland, and serves customers around the world through its own operations and sales network.
The shares are listed on the SIX Swiss Exchange in Switzerland under the code HUBN, and the price on this page is in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Huber+suhner AG (HUBN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 156.20 on 22 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 188 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.9% and over the last three months it fell 19.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 9 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.2% | ||
| From 52-week high | -45.6% | ||
| Momentum | 30 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -19.1% | ||
| 6-month return | -31.6% | ||
| 12-month return, skipping the last month | 30.8% | ||
| Stability (higher is calmer) | 15 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 45.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.9% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 13.07M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.9% |
|---|---|
| 1 month | −14.5% |
| 3 months | −19.1% |
| 6 months | −31.6% |
| 1 year | +11.9% |
| 3 years | +175.0% |
| 5 years | +118.2% |
Signals
| 50-day / 200-day average | 173.25 / 195.82 |
|---|---|
| Golden / death cross (60 days) | Death, 34 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.12 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Apr 2026 | CHF 2.0000 |
| 4 Apr 2025 | CHF 1.9000 |
| 2 Apr 2024 | CHF 1.7000 |
| 31 Mar 2023 | CHF 2.1000 |
| 8 Apr 2022 | CHF 2.0000 |
| 6 Apr 2021 | CHF 1.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.